rs137852581, AR

N. diseases: 5
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Malignant neoplasm of prostate
CUI: C0376358
Disease: Malignant neoplasm of prostate
0.720 GeneticVariation BEFREE T can nevertheless acquire DHT-like activity through an AR helix-10 H874Y prostate cancer mutation. 17591767 2007
Malignant neoplasm of prostate
CUI: C0376358
Disease: Malignant neoplasm of prostate
0.720 GeneticVariation BEFREE SfaNI digestion of AR exon H DNA from normal but not from prostate cancer tissue indicated H874Y is a somatic mutation that occurred before the initial tumor transplant. 9092797 1997
Malignant neoplasm of prostate
CUI: C0376358
Disease: Malignant neoplasm of prostate
0.720 GeneticVariation UNIPROT
PROSTATE CANCER, SOMATIC
CUI: C4015779
Disease: PROSTATE CANCER, SOMATIC
0.700 CausalMutation CLINVAR
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.020 GeneticVariation BEFREE T can nevertheless acquire DHT-like activity through an AR helix-10 H874Y prostate cancer mutation. 17591767 2007
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
0.020 GeneticVariation BEFREE SfaNI digestion of AR exon H DNA from normal but not from prostate cancer tissue indicated H874Y is a somatic mutation that occurred before the initial tumor transplant. 9092797 1997
Neoplasms
CUI: C0027651
Disease: Neoplasms
0.010 GeneticVariation BEFREE Treatment of a CRPC patient-derived xenograft, MDA-PCa-133 expressing H874Y AR mutant with VT-464, reduced the increase in tumor volume in castrate male mice more than twice as much as the vehicle (P < 0.05). 27748439 2016
Prostatic Neoplasms
CUI: C0033578
Disease: Prostatic Neoplasms
0.010 GeneticVariation BEFREE CWR22Rv1 (22Rv1) is an androgen-responsive human prostate carcinoma cell line derived from a primary prostate tumor that expresses mutant (H874Y) androgen receptors (AR) and secretes low levels of prostate specific antigen (PSA). 15249132 2004